Nurses from 28 countries have filed a complaint in the UN alleging human rights violations by EU, UK, Norway, Switzerland, and Singapore for ‘the loss of countless lives’ in the pandemic.
One year has passed since the TRIPS waiver proposal was first tabled at the World Trade Organization, and rich countries persevere in opposing it. This has affected the availability of vaccines, and is having effect on access to diagnostics and therapeutics too
A newly launched campaign by the Third World Network and Development Alternatives with Women for a New Era highlights the questions of gender-based differences in access to Covid-19 vaccines, medicines, therapeutics and equipment
Almost 85% of all COVID vaccines administered till date have been in high income and upper-middle income countries. The poorest countries meanwhile have still only received 0.3% of all vaccine doses.
Sangeeta Shashikant from the Third World Network looks at the position of different countries, how pharmaceuticals are profiting from the crisis, and the urgent need for the negotiations to be fast tracked and concluded.
Immunologist Dr. Satyajit Rath and Newsclick’s Prabir Purkayastha talk about the recent debates on the intellectual property rights on vaccines and the possibilities of mass immunization
Alexander Zaitchik discuss Bill Gates’ recent comments on intellectual property rights in the context of COVID-19 vaccines, his long history as a spokesperson for Big Pharma, and the various struggles across the world for a fairer IPR regime and health for all
What is standing in the way of expanding production and carrying out mass vaccination campaigns across the world?
Private pharma companies and developed nations have created a bottleneck in vaccine distribution through the use of patents and legislation
A proposal made by India and South Africa in October last year to waive certain Intellectual Property Rights (IPR) of COVID vaccines has gained massive support across the world. Despite its potential to prevent millions of avoidable deaths, the US and its allies continue to block the proposal at the WTO.
Three of the world’s most profitable publishing houses have filed a case in Delhi High Court against Sci-Hub and Libgen
After making America sick again, president Donald Trump is trying to compensate for his administration’s failure by buying up the entire stock of Remdesivir from Gilead for the next three months for the US, and leaving nothing for the rest of the world.